Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Teru Hideshima, Ph.D., M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01CA178264 (HIDESHIMA, TERU) Sep 1, 2014 - Aug 31, 2020
    NIH
    Functional and biologic significance of deacetylase3 inhibition in myeloma
    Role: Co-Principal Investigator
  2. P50CA100707 (ANDERSON, KENNETH C.) Sep 1, 2003 - May 31, 2024
    NIH
    SPORE in Multiple Myeloma
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Hideshima T, Anderson KC. Signaling Pathway Mediating Myeloma Cell Growth and Survival. Cancers (Basel). 2021 Jan 08; 13(2). PMID: 33435632.
    Citations:    
  2. Ogiya D, Liu J, Ohguchi H,